ImageneBio, Inc.
IMA•NASDAQ•Healthcare•Biotechnology

About ImageneBio

ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

Company Information

SectorHealthcare
IndustryBiotechnology
CEOKristin Yarema
Founded2019
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websitewww.inmagenebio.com
Phone858 345 6265
Address
12526 High Bluff Drive, Suite 345 San Diego, California 92130 United States

Corporate Identifiers

CIK0001835579
CUSIP45175G207
ISINUS45175G2075
EIN81-1697316
SIC2836

Leadership Team & Key Executives

Dr. Kristin Yarema Ph.D.
Chief Executive Officer, Director and Interim Principal Financial Officer
Dr. Kurinji Pandiyan Ph.D.
Chief Strategy and Operations Officer
Renuka Sivendran Ph.D.
Chief Technical Officer